Allergy Therapeutics PLC
LSE:AGY

Watchlist Manager
Allergy Therapeutics PLC Logo
Allergy Therapeutics PLC
LSE:AGY
Watchlist
Price: 5.42 GBX -3.21% Market Closed
Market Cap: 258.3m GBX
Have any thoughts about
Allergy Therapeutics PLC?
Write Note

Allergy Therapeutics PLC
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Allergy Therapeutics PLC
Income from Continuing Operations Peer Comparison

Comparables:
GSK
AZN
VRNA
HIK
DPH

Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
Allergy Therapeutics PLC
LSE:AGY
Income from Continuing Operations
-ÂŁ50.2m
CAGR 3-Years
N/A
CAGR 5-Years
-73%
CAGR 10-Years
N/A
GlaxoSmithKline PLC
LSE:GSK
Income from Continuing Operations
ÂŁ4.3B
CAGR 3-Years
-3%
CAGR 5-Years
-3%
CAGR 10-Years
-1%
AstraZeneca PLC
LSE:AZN
Income from Continuing Operations
$6.4B
CAGR 3-Years
20%
CAGR 5-Years
25%
CAGR 10-Years
12%
Verona Pharma PLC
NASDAQ:VRNA
Income from Continuing Operations
-$153.7m
CAGR 3-Years
-51%
CAGR 5-Years
-26%
CAGR 10-Years
N/A
Hikma Pharmaceuticals PLC
LSE:HIK
Income from Continuing Operations
$290m
CAGR 3-Years
-15%
CAGR 5-Years
-4%
CAGR 10-Years
-1%
Dechra Pharmaceuticals PLC
LSE:DPH
Income from Continuing Operations
-ÂŁ27.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Allergy Therapeutics PLC's Income from Continuing Operations?
Income from Continuing Operations
-50.2m GBP

Based on the financial report for Dec 31, 2023, Allergy Therapeutics PLC's Income from Continuing Operations amounts to -50.2m GBP.

What is Allergy Therapeutics PLC's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 5Y
-73%

Over the last year, the Income from Continuing Operations growth was -73%.

Back to Top